Ownership history in Aberdeen Group plc · 7 quarters on record
This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 26,740 | -40,917 | -60.5% | 0.00% | $2.7M | $100.99 |
| 2025 Q2 | REDUCED | 67,657 | -40,472 | -37.4% | 0.01% | $4.3M | $63.19 |
| 2025 Q1 | ADDED | 108,129 | +27,612 | +34.3% | 0.01% | $5.7M | $52.97 |
| 2024 Q4 | REDUCED | 80,517 | -32,287 | -28.6% | 0.01% | $4.5M | $55.98 |
| 2024 Q3 | UNCHANGED | 112,804 | — | 0% | 0.01% | $5.9M | $52.39 |
| 2024 Q2 | ADDED | 112,804 | +91,281 | +424.1% | 0.01% | $4.6M | $41.06 |
| 2019 Q1 | INITIATED | 21,523 | — | — | 0.00% | $590K | — |
As of 2025 Q4 — sorted by position size